US Amjevita Sales Slide By Almost Two-Thirds

Amgen’s Humira Biosimilar Turnover Slides In US Ahead Of Fresh Wave Of Launches

Aug 04 2023

• By David Wallace

Amgen saw US sales of its Humira biosimilar drop by nearly two-thirds in Q2 • Source: Shutterstock

More from Biosimilars

More from Products